Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive aging workshop (STRAW) staging system

被引:137
作者
Hale, Georgina E.
Zhao, Xue
Hughes, Claude L.
Burger, Henry G.
Robertson, David M.
Fraser, Ian S.
机构
[1] Univ Sydney, Dept Obstet & Gynaecol, Sydney, NSW 2006, Australia
[2] RTI Int, Res Triangle Pk, NC 27709 USA
[3] Prince Henrys Inst, Clayton, Vic 3168, Australia
[4] Monash Med Ctr, Clayton, Vic 3168, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1210/jc.2007-0066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Female reproductive aging based on changes in menstrual cycle length and frequency progresses through a number of stages as defined by the Stages of Reproductive Aging Workshop (STRAW) staging criteria. Objective: This paper provides a comprehensive description of the endocrine features associated with the STRAW stages. Design: Healthy women aged 21-35 and 45-55 yr submitted three blood samples a week over a single menstrual cycle. They were classified as mid- reproductive age (n = 21), late-reproductive age (n = 16), early menopause transition (n = 16), and late menopause transition (n = 23). Results: There were nine, one, zero, and two anovulatory cycles identified in the late menopause transition, early menopause transition, late-reproductive age, and mid-reproductive age groups, respectively. Ovulatory cycle FSH, LH, and estradiol levels increased with progression of STRAW stage (P = 0.001, P < 0.01, and P < 0.05, respectively), and mean luteal phase serum progesterone decreased (P < 0.01). Early cycle (ovulatory and anovulatory) inhibin B decreased steadily across the STRAW stages (P < 0.01) and was largely undetectable during elongated ovulatory and anovulatory cycles in the menopause transition. Anti- Mullerian hormone decreased markedly (10- to 15-fold) and progressively across the STRAW stages (P < 0.01 and P < 0.001, respectively). Conclusions: Progression through the STRAW stages is associated with elevations in serum FSH, LH, and estradiol and decreases in luteal phase progesterone. The marked fall in inhibin B and particularly anti-Mullerian hormone indicate that they may be useful in predicting STRAW stage but future analyses of early cycle measurements on larger cohorts are needed to draw predictive conclusions.
引用
收藏
页码:3060 / 3067
页数:8
相关论文
共 38 条
[1]   HORMONE PROFILES AND PSYCHOLOGICAL SYMPTOMS IN PERI-MENOPAUSAL WOMEN [J].
BALLINGER, CB ;
BROWNING, MCK ;
SMITH, AHW .
MATURITAS, 1987, 9 (03) :235-251
[2]  
Burger H G, 2000, Climacteric, V3, P17, DOI 10.3109/13697130009167595
[3]   Hormonal changes in the menopause transition [J].
Burger, HG ;
Dudley, EC ;
Robertson, DM ;
Dennerstein, L .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 57, 2002, 57 :257-275
[4]   DIAGNOSTIC ROLE OF FOLLICLE-STIMULATING-HORMONE (FSH) MEASUREMENTS DURING THE MENOPAUSAL TRANSITION - AN ANALYSIS OF FSH, ESTRADIOL AND INHIBIN [J].
BURGER, HG .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (01) :38-42
[5]  
Dennerstein L, 2002, FERTIL STERIL, V77, pS42
[6]   Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3 [J].
Fanchin, R ;
Schonäuer, LM ;
Righini, C ;
Guibourdenche, J ;
Frydman, R ;
Taieb, J .
HUMAN REPRODUCTION, 2003, 18 (02) :323-327
[7]   High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status [J].
Fanchin, R ;
Taieb, J ;
Lozano, DHM ;
Ducot, B ;
Frydman, R ;
Bouyer, J .
HUMAN REPRODUCTION, 2005, 20 (04) :923-927
[8]   DETECTION OF DIMERIC INHIBIN THROUGHOUT THE HUMAN MENSTRUAL-CYCLE BY 2-SITE ENZYME-IMMUNOASSAY [J].
GROOME, NP ;
ILLINGWORTH, PJ ;
OBRIEN, M ;
COOKE, I ;
GANESAN, TS ;
BAIRD, DT ;
MCNEILLY, AS .
CLINICAL ENDOCRINOLOGY, 1994, 40 (06) :717-723
[9]   Measurement of dimeric inhibin B throughout the human menstrual cycle [J].
Groome, NP ;
Illingworth, PJ ;
OBrien, M ;
Pai, R ;
Rodger, FE ;
Mather, JP ;
McNeilly, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04) :1401-1405
[10]   Clinical review 139 - Endometrial cancer: Hormonal factors, the perimenopausal "window of risk," and isoflavones [J].
Hale, GE ;
Hughes, CL ;
Cline, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :3-15